Materias dentro de su búsqueda.
Mostrando 1,661 - 1,680 Resultados de 5,148 Para Buscar '"Ph. D."', tiempo de consulta: 1.16s Limitar resultados
  1. 1661
    “…Gibbons, PhD, GSK: Employee|GSK: Stocks/Bonds Myriam Drysdale, PhD, GSK: Employee|GSK: Stocks/Bonds Jane Wang, MS, GSK: Funding to conduct study|Vir Biotechnology, Inc: Funding to conduct study Emily Lloyd, MSc, GSK: Employee|GSK: Stocks/Bonds…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    510. Real-world Effectiveness of Sotrovimab for COVID-19: Evidence from United States (US) Administrative Claims Data
  2. 1662
    “…DISCLOSURES: Ventzislav Vassilev, PhD, GlaxoSmithKlein Vaccines (Employee), Lan Lin, MD, GlaxoSmithKlein Vaccines (Employee), Alfredo Nicosia, PhD, ReiThera (Employee, Shareholder), Antonella Folgori, PhD, ReiThera (Employee), ReiThera (Employee, Shareholder. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LB10. A Randomized, Double-Blind, Placebo-Controlled Efficacy Trial of a Vaccine to Prevent Chronic Hepatitis C Virus Infection in an at-Risk Population
  3. 1663
    “…DISCLOSURES: Reed Johnson, PhD, Pfizer (Research Grant or Support) Angelyn Fairchild, BA, Pfizer (Research Grant or Support) Dale Whittington, PhD, Pfizer (Research Grant or Support) Jessica Presa, MD, Pfizer (Employee) Amit Srivastava, PhD, Pfizer (Employee) Liping Huang, MD, MA, MS, Pfizer (Employee)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2. Understanding Patient Preferences for Meningococcal Serogroup B Vaccines in the United States
  4. 1664
    “…Jansen, PhD, Pfizer (Employee, Shareholder) William C. Gruber, MD, Pfizer (Employee, Shareholder) Wendy Watson, MD, Pfizer (Employee, Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    16. A Randomized Phase 1 Study of a Novel Pneumococcal Conjugate Vaccine in Healthy Japanese Adults in the United States
  5. 1665
    “…(Consultant) Yoshinori Yamano, PhD, Shionogi & Co., Ltd. (Employee)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1252. In Vitro Activity of Cefiderocol Against Metallo-β-Lactamase-Producing Gram-Negative Bacteria Collected in North America and Europe Between 2014 and 2017: SIDERO-WT-2014–2016 Studies
  6. 1666
    “…(Employee, Shareholder) Steve Rittenhouse, PhD, GlaxoSmithKline (Employee, Shareholder) Jianzhong Huang, PhD, GlaxoSmithKline (Employee, Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1249. Genetic Evidence That Gepotidacin Shows Well-balanced Dual Targeting against DNA Gyrase And Topoisomerase IV in Neisseria gonorrhoeae
  7. 1667
    “…Talbird, MSPH, RTI Health Solutions (Employee) Ya-Ting Chen, PhD, Merck & Co., Inc. (Employee, Shareholder) Mawuli K. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1386. Current Estimates of the Impact of Routine Childhood Immunizations in Reducing Vaccine-Preventable Diseases in the United States
  8. 1668
    “…(Employee) Adel Moussa, PhD, Atea Pharmaceuticals, Inc. (Employee) Xiao-Jian Zhou, PhD, Atea Pharmaceuticals, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1265. AT-527, an Oral Purine Nucleotide Prodrug Exhibiting Potent In Vitro Antiviral Activity Against Human Coronaviruses, Including SARS-CoV-2
  9. 1669
    “…DISCLOSURES: Tanaz Petigara, PhD, Merck & Co., Inc. (Employee, Shareholder) Xinyi Ng, PhD, Merck & Co., Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1399. Parental Perceptions of the Childhood Vaccination Schedule and Combination Vaccines in the United States (US)
  10. 1670
    “…DISCLOSURES: Parviz Ghahramani, PhD, PharmD, MSc, MBA, Consultant to ConatFect (Consultant) Tatiana Khariton, PhD, Consultant to ConatFect (Consultant) Joannellyn Chiu, PhD, Consultant to ConatFect (Consultant) Cara Cassino, MD, ContraFect Corporation (Employee)ContraFect Corporation (Employee)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1324. Target Attainment of Exebacase, a First-In-Class Antibacterial Lysin, to Determine Optimal Doses for Adult Patients with Staphylococcus aureus (S. aureus) Bloodstream Infections (Bacteremia) Including Endocarditis
  11. 1671
    “…Rodriguez, PhD, Monogram Biosciences (Employee) Christos J. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    959. HIV-1 DNA Testing Identifies Drug Resistance in Viremic Patients with Pan-Sensitive Plasma Virus
  12. 1672
    “…DISCLOSURES: Ya-Ting Chen, PhD, Merck & Co., Inc. (Employee, Shareholder) Xinyi Ng, PhD, Merck & Co., Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1400. Physician Attitudes towards Combination Vaccine Use in Infants up to 24 months of age in the United States (US)
  13. 1673
    “…DISCLOSURES: Krystyna Kazmierczak, PhD, IHMA (Employee)Pfizer, Inc. (Consultant) Greg Stone, PhD, AztraZeneca (Shareholder, Former Employee)Pfizer, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1568. In Vitro Activity of Ceftazidime-Avibactam and Comparator Agents Against Enterobacterales and Pseudomonas aeruginosa Collected < 48 Hours and ≥48 Hours Post-Admission from Pediatric Patients, ATLAS Surveillance Program 2015-2018
  14. 1674
    “…Sahm, PhD, IHMA (Employee)Pfizer, Inc. (Consultant)Shionogi & Co., Ltd. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1609. Epidemiology and Susceptibility to Imipenem/Relebactam of Gram-Negative Pathogens from Patients with Lower Respiratory Tract Infections – SMART United States 2017-2018
  15. 1675
    “…Sahm, PhD, IHMA (Employee)Pfizer, Inc. (Consultant)Shionogi & Co., Ltd. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1603. Comparison of Ceftolozane/Tazobactam, Ceftazidime/Avibactam, and Meropenem/Vaborbactam Activity Against P. aeruginosa: A Multicenter Evaluation
  16. 1676
    “…(Employee) Sachi Kanazawa, PhD, Shionogi & Co., Ltd. (Employee) Naoki Kohira, PhD, Shionogi & Co., Ltd. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1106. Evaluation of Penetration of Cefiderocol into Cerebrospinal Fluid Using a Rat Meningitis Model
  17. 1677
    “…DISCLOSURES: David Huang, MD, PhD, Lysovant (Consultant) Helio S. Sader, MD, PhD, FIDSA, AbbVie (formerly Allergan) (Research Grant or Support)Basilea Pharmaceutica International, Ltd. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1054. Activity of a Anti-staphylococcal Lysin, LSVT-1701: In vitro Susceptibility of Staphylococcus aureus and Coagulase-Negative Staphylococci (CoNS) Global Clinical Isolates (2002 to 2019)
  18. 1678
    “…(Employee) Yoshinori Yamano, PhD, Shionogi (Employee) Meredith Hackel, PhD MPH, IHMA (Employee)Pfizer, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1058. In Vitro and In Vivo Antibacterial Activity of Cefiderocol against Burkholderia spp
  19. 1679
    “…DISCLOSURES: Morgan Marks, PhD, ScM, Merck & Co Inc. (Employee) Patricia Saddier, MD, PhD, Merck & Co Inc (Employee) Nicola P. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    22. An Innovative Approach to Examining the Waning of Vaccine Effectiveness Using Automated Healthcare Data
  20. 1680
    “…DISCLOSURES: Joshua Wolf, MBBS, PhD, FRACP, Karius Inc. (Research Grant or Support) Joshua Wolf, MBBS, PhD, FRACP, Nothing to disclose Paul Thomas, PhD, Cytoagents (Consultant)Immunoscape (Consultant)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    437. Longitudinal Plasma Cytokine Profiles Differentiating COVID-19 Severity Groups
Herramientas de búsqueda: RSS